维普期刊资源整合服务平台（V6.5）

40篇 您的检索式：作者名="OBASAJU C"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Phase Ⅰ study of paclitaxel and estramustine:preliminary activity in hormone-refractory prostate cancer显示文摘	Hudes G R Obasaju C Chapman A	1995	Semin Oncol1995，22，：	1
2	Randomized phase Ⅲ trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer显示文摘	Reynolds C Obasaju C Schell MJ	2009	J Clin Oncol2009，27，34：	1
3	Randomized phase Ⅲ trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in Non small cell lung cancer显示文摘	Reynolds C Obasaju C Schell M J		0，，34：	1
4	Update of phase1 ⅡTrial of pemetrexed plus carboplatin in patients with advanced non-sm all-cell lung cancer显示文摘	Koshy S Obasaju C Fossella FV	2004	Proc Am Soc Clin Oncol2004，22，：	1
5	Randomized phase ill trial of gemcitabine-based chemotherapy with in situ RRM I and ERCC I protein levels for response predic?tion in non-small-cell lung cancer显示文摘	Reynolds C Obasaju C Schell MJ	2009	J Clin Oncol2009，27，34：	1
6	Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non- small-cell lung cancer显示文摘	REYNOLDS C OBASAJU C SCHELL M J	2009	J C/in Oncol2009，27，34：	1
7	Randomized phase 111 trial of Gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer显示文摘	Reynolds C Obasaju C Schell MJ	2009	J Clin Oncol2009，27，34：	1
8	Randomized phase Ⅲ trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lungcancer显示文摘	Reynolds C Obasaju C Schell MJ	2009	J Clin Oncol2009，27，34：	1
9	Randomized phase trial of Gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small- cel lung cancer显示文摘	Reynolds C Obasaju C Schell MJ	2009	J Clin Oncol2009，27，34：	1
10	Randomized phase III trial of gemcitahine- based chemotherapy with in situ RRMI and ERCCI protein levels for response prediction in non-small-cell lung cancer显示文摘	REYNOLDS C OBASAJU C SCHELL M J	2009	J Clin Oncol2009，27，34：	1
11	Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRMI and ERCCI protein levels for response pre?diction in non-small cell lung cancer显示文摘	Reynolds C Obasaju C Schell MJ	2009	J Clin Oncol2009，27，34：	1
12	Randomized phase Ⅲ tnal of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer显示文摘	Reynolds C Obasaju C Schell M J	2009	J Clin Oncol2009，27，34：	1
13	Randomized phase Ⅲ trial of gemcitabine-based chemotherapy'with in situ RRM1 and ER- CC1 protein levels for response prediction in non-small-cell lung cancer显示文摘	Reynolds C Obasaju C Schell MJ	2009	J Clin Oncol2009，27，34：	1
14	Randomized PhaseⅢtrial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small cell lung cancer显示文摘	REYNOLDS C OBASAJU C SCHELL M	2009	J Clin Oncol2009，27，34：	1
15	Randomized phase Ⅲ trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 portein levels for response prediction in non-small-cell lung 显示文摘	Reynolds C Obasaju C Schell M J	2009	J Clin Oncol2009，27，34：	1
16	Randomized phase trial of Gemcitabine-based chemotherapy with in situ RRMI and ERCC1 protein levels for response prediction in non-small-cell lung cancer 显示文摘	Reynolds C Obasaju C Schell M J	2009	J Clin 0ncol2009，27，34：	1
17	Randomized phase III trial of Gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in NSCLC显示文摘	Reynolds C Obasaju C Schell MJ		0，，34：	1
18	Randomized phase m trial of Gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small cell lung cancer 显示文摘	Reynolds C Obasaju C Schell M J	2009	J Clin Oncol2009，27，34：	1
19	Randomized phase Ⅲ trial of gemcitabine - based chemotherapy with in situ RRM1 and ER- CC1 protein levels for response prediction in non - small - cell lung cancer显示文摘	Reynolds C Obasaju C Schell MJ	2009	J Clin 0ncol2009，27，34：	1
20	Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response predic- tion in non-small-cell lung cancer 显示文摘	Reynolds C Obasaju C Sche11 M J	2009	J Clin Oncol2009，27，34：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示